90
Participants
Start Date
September 10, 2022
Primary Completion Date
December 20, 2022
Study Completion Date
January 10, 2023
Blood sampling
One additional blood tube will be collected for each patient included in the study using PAXgene Blood ccfDNA Tubes
Lead Sponsor
Centre Hospitalier Sud Francilien
OTHER
CGenetix
INDUSTRY